The BDNF effects on dendritic spines of mature hippocampal neurons depend on neuronal activity by Yves Kellner et al.
ORIGINAL RESEARCH ARTICLE
published: 20 March 2014
doi: 10.3389/fnsyn.2014.00005
The BDNF effects on dendritic spines of mature
hippocampal neurons depend on neuronal activity
Yves Kellner , Nina Gödecke , Tobias Dierkes , Nils Thieme , Marta Zagrebelsky*† and Martin Korte*†
Division of Cellular Neurobiology, Zoological Institute, TU Braunschweig, Braunschweig, Germany
Edited by:
Nancy Ip, The Hong Kong University
of Science and Technology, China
Reviewed by:
Lucas Pozzo-Miller, The University of
Alabama at Birmingham, USA
Christian Henneberger, University of
Bonn, Germany
*Correspondence:
Marta Zagrebelsky and Martin Korte,
Division of Cellular Neurobiology,
Zoological Institute, TU
Braunschweig, Germany,
Spielmannstr 7, 38106
Braunschweig, Germany
e-mail: m.korte@tu-bs.de;
m.zagrebelsky@tu-bs.de
†These authors have contributed
equally to this work.
The fine tuning of neural networks during development and learning relies upon both
functional and structural plastic processes. Changes in the number as well as in the size
and shape of dendritic spines are associated to long-term activity-dependent synaptic
plasticity. However, the molecular mechanisms translating functional into structural
changes are still largely unknown. In this context, neurotrophins, like Brain-Derived
Neurotrophic Factor (BDNF), are among promising candidates. Specifically BDNF-TrkB
receptor signaling is crucial for activity-dependent strengthening of synapses in different
brain regions. BDNF application has been shown to positively modulate dendritic and spine
architecture in cortical and hippocampal neurons as well as structural plasticity in vitro.
However, a global BDNF deprivation throughout the central nervous system (CNS) resulted
in very mild structural alterations of dendritic spines, questioning the relevance of the
endogenous BDNF signaling in modulating the development and the mature structure of
neurons in vivo. Here we show that a loss-of-function approach, blocking BDNF results
in a significant reduction in dendritic spine density, associated with an increase in spine
length and a decrease in head width. These changes are associated with a decrease in
F-actin levels within spine heads. On the other hand, a gain-of-function approach, applying
exogenous BDNF, could not reproduce the increase in spine density or the changes in
spine morphology previously described. Taken together, we show here that the effects
exerted by BDNF on the dendritic architecture of hippocampal neurons are dependent on
the neuron’s maturation stage. Indeed, in mature hippocampal neurons in vitro as shown
in vivo BDNF is specifically required for the activity-dependent maintenance of the mature
spine phenotype.
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INTRODUCTION
Neurotrophins are essential for multiple aspects of neu-
ronal development and function. Especially Brain-derived
Neurotrophic Factor (BDNF) has been shown to play an impor-
tant role in neuronal survival and in the maintenance of several
neuronal systems. In addition, BDNF has been implicated in
numerous processes of functional and structural synaptic plas-
ticity (Gottmann et al., 2009; Park and Poo, 2012; Zagrebelsky
and Korte, 2013). The role of BDNF has been extensively ana-
lyzed in vitro upon the application of exogenous BDNF. The
data obtained support the notion that during development BDNF
is involved in regulating the fine-tuning of the cortical net-
work by selectively enhancing dendritic growth in an activity-
dependent manner (Mcallister et al., 1995, 1996; Horch et al.,
1999). Application of exogenous BDNF to developing primary
hippocampal neurons has been shown to result in a signifi-
cant increase in the number of primary neurites as well as an
increase in neurite complexity and length (Ji et al., 2005; Kwon
and Sabatini, 2011). Furthermore, dendritic spine density and
morphology of mature primary hippocampal neurons are signif-
icantly influences by a BDNF application (Ji et al., 2005, 2010).
Similarly, mature organotypic hippocampal neurons treated with
BDNF show a significant increase in dendritic spine density and
in the number of synapses (Tyler and Pozzo-Miller, 2001, 2003).
Taken together, the in vitro studies described above strongly
support the notion that, in the hippocampus exogenous BDNF
promotes dendritic formation and growth during development
and regulates dendritic spine density and morphology in mature
neurons. But as strong as the evidence for a role of BDNF in
modulating dendritic architecture might appear, the prepara-
tion techniques (Danzer et al., 2004) and the culture conditions
(Chapleau et al., 2008) have been shown to influence the expres-
sion levels as well as the cellular response to BDNF, possibly
confounding the analysis under these conditions. Suggestive for
a role of BDNF in vivo is the correlation between the physiolog-
ical variability in BDNF expression levels in the mouse dentate
gyrus and the dendritic spine density in granule cells (Stranahan,
2011). Moreover, a reduction in BDNF serum levels is associ-
ated to a reduction in hippocampus volume in aging humans
(Erickson et al., 2011) as well as in dendritic complexity and
spine density in senescent rats (Von Bohlen Und Halbach, 2010).
The in vivo role of BDNF has been very difficult to evaluate in
the post-natal brain as bdnf−/− mouse mutants die too early for
the role of BDNF to be assessed after its increased post-natal
expression caused by neuronal activity (Zafra et al., 1990; Hong
et al., 2008). The analysis of bdnf+/− mouse mutants, showing
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reduced BDNF levels provided evidence that, in vivo BDNF plays
an important role in the induction of LTP in the hippocampus
(Korte et al., 1995), the acquisition of extinction learning (Psotta
et al., 2013) and in the structural rearrangement of adult corti-
cal circuitry upon increased sensory input (Genoud et al., 2004).
On the other hand, in bdnf+/− mice synapse density and spine
morphology are indistinguishable from those in WT mice (Korte
et al., 1995; Genoud et al., 2004) and a compensatory increase in
TrkB receptor expression occurs (Carreton et al., 2012), leaving
open the question of whether BDNF modulates dendritic archi-
tecture in vivo. Thus, a number of studies have been performed
using different conditional gene targeted mouse lines and Cre-
loxP-mediated excision of bdnf (Rios et al., 2001; Gorski et al.,
2003; Baquet et al., 2004; He et al., 2004; Chan et al., 2006, 2008;
Monteggia et al., 2007; Unger et al., 2007; Rauskolb et al., 2010).
Surprisingly, the effect on excitatory neurons in the hippocampus
and cortex of a global BDNF deprivation throughout the cen-
tral nervous system (CNS) is extremely mild when compared to
the effects observed upon a BDNF application in vitro. Rauskolb
et al. (2010) showed that in a Tau-BDNFKO mouse the volume
of the cortex is only slightly reduced and the one of the hip-
pocampus unchanged. Accordingly, dendritic complexity of CA1
pyramidal cells is only mildly reduced and while no changes could
be observed in dendritic spine density the spine type distribu-
tion in Tau-BDNFKO neurons is significantly shifted toward a
more immature phenotype, pointing to a specific role of BDNF
in the maintenance of mature dendritic spines in the mature
hippocampus. These results are consistent with the observation
that a conditional deletion of TrkB in the hippocampus does not
affect the gross dendritic morphology of CA1 pyramidal neurons
(Minichiello et al., 1999; Luikart et al., 2005).
So overall it is noteworthy that while most of the published
data supporting a role for BDNF inmodulating dendrite and den-
dritic spine morphology derive from in vitro experiments apply-
ing exogenous BDNF, a role for endogenous BDNF in this context
is still unclear. Moreover, in vivo the effects of endogenous BDNF
in modulating the structure of neurons seem to be extremely spe-
cific, depending on the developmental stage, the brain area as well
as the cell-type. Therefore, in this study we set out to address the
discrepancies in the role of BDNF in modulating the architecture
of mature hippocampal neurons. In order to contribute to a bet-
ter understanding of the BDNF activity, we analyzed the effects of
several manipulations of its signaling on dendrites and dendritic
spines at different developmental stages and under different lev-
els of neuronal activity in primary neuronal cultures. The results
we obtained in our culture system confirm the observations pre-
viously obtained in vivo and show that BDNF exerts a highly
precise role on different aspects of neuronal architecture in an
age-dependent manner. In mature hippocampal neurons in vitro,
as shown in vivo endogenous BDNF is specifically required for the
activity-dependent maintenance of the mature spine phenotype.
MATERIALS AND METHODS
PREPARATION OF PRIMARY HIPPOCAMPAL CULTURES
Primary hippocampal cultures were prepared fromC57BL/6mice
at embryonic day 18. All procedures were approved by guide-
lines from the Animal Committee on Ethics in the Care and
Use of Laboratory Animals of TU Braunschweig. Embryos were
decapitated and the brains were kept in ice-cold Gey’s balanced
salt solution (GBSS) containing of 1% kynurenic acid, 1% glu-
cose and adjusted to pH 7.2. The dissected hippocampi were
incubated for 30min in trypsin/EDTA at 37◦C and then mechan-
ically dissociated. Cells were plated at high density (105/well) on
poly-L-lysine-coated coverslips (13mm) and kept in Neurobasal
medium (Invitrogen) supplemented with 2% B27 (Invitrogen)
and 0.5mM Glutamax at 37◦C, 5% CO2, and 99% humidity.
For analysis of neurite growth in 3–6 days in vitro to the cells
were plated at a density of 104 cells per well. For the experiments
performed in high Magnesium (Mg2+) containing medium, the
cells were plated at a density of 70,000 cells per well and kept
in Neurobasal medium (Gibco) supplemented with 2% BSA
(Gibco), 200μM L-Glutamin and 1% 100 × N2 (Invitrogen) at
37◦C, 5% CO2, and 99% humidity.
TRANSFECTION OF PRIMARY HIPPOCAMPAL NEURONS
Hippocampal neurons were transfected at various time points
with a farnesylated form of the enhanced green fluorescent pro-
tein (fEGFP) using Lipofectamine 2000 according to the manu-
facturer’s protocol. To specifically label F-actin without adverse
effects on actin dynamics the cells were co-transfected with fEGFP
and an expression plasmid for the Lifeact peptide fused to a red
fluorescent protein (RFP-LA) (Riedl et al., 2008, 2010). Briefly,
0.8μg DNA or, for a co-transfection 0.4μg pfEGFP and 0.6μg
pRFP-LA and 2μl Lipofectamine 2000 per well were mixed in
100μl Neurobasal medium, and added to the cultures drop-
wise. After 50min of incubation the transfection medium was
exchanged for the original Neurobasal medium. The cultures were
kept for 24 h at 37◦C, 5% CO2, and 99% humidity before the
treatment.
TREATMENT OF PRIMARY HIPPOCAMPAL NEURONS
Twenty-four hours after transfection, 1/3 of the culture medium
was exchanged for a medium containing 0.1% Bovine Serum
Albumine (BSA, Sigma; 0.1% BSA/PBS) as a control treatment or
0.1% BSA combined with BDNF (Recombinant Human BDNF,
40 ng/ml, R&D Systems), BDNF blocking antibodies (BDNF-Abs,
1:500, M. Sendtner, Wuerzburg Germany) or TrkB receptor bod-
ies (TrkB-Fc, Recombinant Human TrkB-Fc, 500 ng/ml, R&D
Systems). The BSA was added to the medium to prevent BDNF
or the antibodies from sticking to the plastic (Chen et al., 1999).
In a second set of control experiments the cultures were kept in
Neurobasal medium without addition of BSA. As no significant
difference between the two control conditions could be observed
only the BSA control was used in the result part. The cultures were
fixed 24 h after the treatment in 4% paraformaldehyde (PFA) in
0.1M phosphate buffer (PBS), washed andmounted with an anti-
fading aqueous mounting medium (Fluoro-Gel Emsdiasum).
In a second set of experiments neuronal activity was
reduced in primary hippocampal cultures by increasing the
Mg2+concentration in the medium. Indeed, Mg2+ decreases the
activation of voltage-gated channels thereby reducing neuronal
excitability (Mayer and Westbrook, 1987; Dribben et al., 2010).
To avoid effects on the early developmental stages Mg2+ concen-
tration in the medium was increased starting at 7DIV from 1.5
Frontiers in Synaptic Neuroscience www.frontiersin.org March 2014 | Volume 6 | Article 5 | 2
Kellner et al. BDNF effects on dendritic spines
to 3.5mM by adding MgCl2, for 2 weeks and fresh medium was
added once a week. The treatment with BDNF or TrkB receptor
bodies was performed for 24 h either in low (1.5mM) or high
(3.5mM) Mg2+ containing medium.
IMMUNOCYTOCHEMISTRY
Primary hippocampal cultures (6 or 23DIV) were fixed with
4% PFA, permeabilized and blocked with a solution containing
0.2% Triton X-100, 10% goat serum, and 0.1% BSA in PBS. A
rabbit polyclonal antibody anti-c-fos (Santa Cruz Biotechnology,
Inc., sc-52; dilution 1:500), a mouse monoclonal antibody anti-
CaMKII (Invitrogen, dilution 1:500), a rabbit polyclonal anti-
MAP2 (Abcam, dilution 1:500) or a primary rabbit monoclonal
anti-phospho-TrkA (Tyr674/675)/TrkB (Tyr706/707) antibody
(Cell Signaling Technology; dilution 1:200) were diluted in block-
ing solution (10% goat serum and 0.1% BSA in PBS) and
incubated at 4◦C overnight. Secondary anti-rabbit or anti-mouse
antibodies conjugated with Cy2, Cy3, or Cy5 (Jackson Immuno
Research) were diluted 1:500 in PBS and incubated for 2 h at room
temperature. Alexa Fluor 350 phalloidin (Lifetechnologies) was
diluted 1:50 in PBS and incubated for 3 h at room temperature to
selectively stain F-actin. Finally, cultures were counterstained with
DAPI (4′,6-diamidino-2-phenylindole) (Biotium) diluted 1:1000
in PBS for 5min, washed and mounted using an anti-fading
aquous mounting medium (Fluoro-Gel Emsdiasum).
NEURON SELECTION
The transfection of the fEGFP expression plasmid under the
control of the CMV promoter resulted in the intense labeling
of the entire dendritic arbor as well as of all dendritic spines
of individual pyramidal neurons. A small number of individ-
ual pyramidal neurons were transfected in each culture allowing
to following the complete dendritic processes of each labeled
neuron. Only non-overlapping labeled neurons were selected for
our analysis allowing for an unambiguous reconstruction of the
entire dendritic tree as well as the analysis for the spine density.
Degenerating neurons were identified according to the presence
of retraction bulbs and fragmentation of the dendritic processes
and excluded from the analysis. Due to a recent report showing
that Mg2+ (5 to 10mM) increases neuronal apoptosis in primary
hippocampal neurons (Dribben et al., 2010), special care was used
in selecting neurons kept in high magnesium medium (3.5mM).
Indeed, all neurons selected for the analysis showed a healthy cell
body and dendritic tree with no signs of apoptosis.
NEURONAL IMAGING AND ANALYSIS
The neurons selected for analysis were imaged using an Axioplan
2 microscope equipped with an ApoTome module (Zeiss). Each
neuron was first imaged using a 20× objective [1.25 numeri-
cal aperture (NA)] and the images were used to analyze den-
dritic complexity and length using a Sholl analysis (Sholl,
1953). The neurons were traced using the Neurolucida soft-
ware (MicroBrightField), and the Sholl analysis was obtained
with Neuroexplorer software (MicroBrightField), calculating the
cumulative number of dendritic intersections at 10μm interval
distance points starting from the cell body. The total number of
crossings for each cell was used as an index for total dendritic
complexity. The total neurite length, number of primary neu-
rites and number of branching points of 6DIV neurons were
analyzed by tracing MAP2 labeled neurites using the NeuronJ
(Meijering et al., 2004) plugin for ImageJ (NIH) Software. Spine
density was measured separately for portions of selected second
or third order dendrite branches and imaged using a 63× objec-
tive (1.32 NA) acquiring three-dimensional stacks z-sectioned at
0.5μm. The number of spines and the dendritic length were
measured using the ImageJ software. The number of spines was
normalized per micrometer of dendritic length and a minimal
length of 250μm of dendrite per cell was analyzed. The max-
imal spine head diameter and maximal spine length (from the
dendritic shaft to the spine head tip) were measured on three-
dimensional stacks using the ImageJ (NIH) software. To examine
the actin content in dendritic spine heads the mean fluorescent
intensity of RFP-lifeact was measured with the area selection tool
of ImageJ and normalized to the mean fluorescent intensity of
the dendritic shaft (for normalization of the RFP overexpression,
Figure 3B, indicated with the arrow heads). RFP-Lifeact and the
immunocytochemistry for c-fos and phosphorylated TrkB were
imaged keeping a constant exposure time. The mean fluores-
cent intensity values for the immunocytochemistry of c-fos and
phosphorylated TrkB were measured with ImageJ (NIH) and nor-
malized to the control condition. The analysis was performed
blindly.
CALCIUM IMAGING
Primary hippocampal cultures 16 and 23DIV were loaded with
calcium indicator by incubating them for 15min with the indica-
tor solution (50μg Oregon Green 488 BAPTA-1 AM (Invitrogen),
dissolved in 50μl DMSO and 2.5% Pluronic acid) at 37◦C, 5%
CO2, and 99% humidity. The cells were then transferred to HBSS
(Hanks balanced salt solution) and kept 45min at 37◦C, 5% CO2,
and 99% humidity. The coverslips were thentransferred to the
recording chamber, continuously perfused with HBSS and kept
at 32◦C. The live imaging was performed using an Olympus
BX61WI microscope system (Cell∧M software) and a CCD cam-
era (VisiCam QE, Visitron Systems). Images were recorded at
6Hz for 75 sec with an Olympus 20× water immersion objective
(0.95 NA XLUMPLAN FL, Olympus), whereby a pixel resolu-
tion of 0.77μm/pixel was achieved. A frame rate of 150ms and
an exposure time of 61ms were used. Primary hippocampal cul-
tures were treated with BSA (serial 0.1% BSA/1× PBS) or BDNF
(RecombinantHuman BDNF, 40 ng/ml, R&D Systems) by a 5min
bath-application.
The analysis of calcium transients was performed using ImageJ
(NIH) and calculating the fluorescence changes as average of
all pixels within regions of interests (ROIs). The ROIs were set
around the cell bodies of the neurons. For the background sub-
traction the ROI was drawn on a neighboring area containing
neuropil. The resulting changes in the intracellular calcium con-
centration are represented as F/F0 in percent, where F0 is the
fluorescence at resting conditions [F/F0 = (F − F0)/F0] taken
before the application of BDNF (Lang et al., 2006). In addition to
it we generated using the plugin “reslice” of the ImageJ Software
a pseudo-line scan to visualize changes in the fluorescence inten-
sity for the whole F-stack. In the pseudo-line scan the y-axis
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corresponds to the respective line drawn on the stack whereas the
x-axis corresponds to time.
STATISTICAL ANALYSIS
The statistical analysis was performed using Microsoft Excel or
GraphPad Prism. The data obtained were compared between two
different experimental conditions using an unpaired two-tailed
Student’s t-test. Data including more than 2 different groups
were analyzed using a One-Way ANOVA followed by a post-hoc
Tukey’s Multiple Comparison Test. Values of p = 0.05 were con-
sidered significant and plotted as follows ∗p < 0.05; ∗∗p < 0.01;
∗∗∗p < 0.001. All data are indicated as mean ± s.e.m.
RESULTS
ENDOGENOUS BDNF REGULATES DENDRITIC SPINE DENSITY AND
MORPHOLOGY IN MATURE PRIMARY HIPPOCAMPAL NEURONS
In view of the discrepancy existing between a described action
of exogenous BDNF in modulating the dendritic architecture
of hippocampal neurons in vitro (Tyler and Pozzo-Miller, 2001;
Ji et al., 2005, 2010) and previous data showing that a global
deprivation of BDNF throughout the CNS in vivo results in only
minimal morphological alterations of mature hippocampal neu-
rons (Minichiello et al., 1999; Zakharenko et al., 2003; Rauskolb
et al., 2010, for a review see Zagrebelsky and Korte, 2013),
we analyzed the role of BDNF in modulating dendritic spine
number and spine morphology as well as dendritic architecture
of primary hippocampal neurons. The dendrite and dendritic
spine architecture of mature 3-week-old (22DIV) primary hip-
pocampal neurons (Papa et al., 1995), expressing a membrane
targeted farnesylated EGFP (fEGFP; Figure 1B) and identified
as excitatory by their pyramidal like morphology (Figure 1B)
and by the expression of the Ca2+/calmodulin-dependent pro-
tein kinase (CaMKII; Figure 1B inserts) were analyzed upon
the application of either a gain- or loss-of-function approach
for BDNF (Figure 1A). While 22DIV fEGFP-expressing neu-
rons treated for 24 h with exogenous BDNF showed no obvious
alterations in dendritic spine density when compared to control
neurons, (Figure 1B′), treating the neurons with BDNF function
blocking antibodies (BDNF-Abs) led to a strong reduction in
dendritic spine density (Figure 1B′). This observation was con-
firmed by the quantification of dendritic spine density showing
no significant difference between BDNF and control treated cells
(Figure 1C, Table S1). On the other hand, a significant reduc-
tion in dendritic spine density was observed for neurons treated
with BDNF blocking antibodies (Figure 1C, Table S1; control vs.
BDNF-Abs, p < 0.001; BDNF vs. BDNF-Abs p < 0.001). These
observations suggest that while the endogenous BDNF may be
crucial for the maintenance of dendritic spines in mature pri-
mary hippocampal neurons, exogenous BDNF does not play a
role in this context. We next assessed whether BDNF regulates
spine morphology in mature hippocampal neurons by analyz-
ing the effects of adding or blocking BDNF on dendritic spine
head width and length. When compared spine head width as well
as spine length (Figure 1B′) did not show any major difference
after a 24 h treatment with BDNF in comparison to the control
condition. On the other hand neurons treated with BDNF block-
ing antibodies showed clearly elongated and thinner spines than
control neurons (Figure 1B′). Indeed, quantification of spine
morphology upon BDNF antibody treatment showed a signifi-
cant decrease in spine head width (Figure 1D, Table S1; control
vs. BDNF-Abs and BDNF vs. BDNF-Abs, p < 0.05) associated
to a significant increase in dendritic spine length (Figure 1E,
Table S1; control vs. BDNF-Abs p < 0.01, BDNF vs. BDNF-Abs
p < 0.001). Treatment with exogenous BDNF did not result in
any significant change in dendritic spine head width (Figure 1D,
Table S1). Under these conditions dendritic spine length was
only slightly reduced when compared to controls but significantly
lower than in neurons treated with BDNF blocking antibod-
ies (Figure 1E, Table S1; BDNF vs. BDNF-Abs, p < 0.001). Next
dendritic spines were separated according on their stage of matu-
ration into four categories based on their head width. Comparing
the effect of the different treatments within each spine head cat-
egory showed a significant increase in spines with a small head
(<0.3μm; control vs. BDNF-Abs p < 0.001, BDNF vs. BDNF-
Abs p < 0.01) accompanied by a significant decrease in larger
spine heads (≥0.5μm <1μm; control vs. BDNF-Abs p < 0.01,
BDNF vs. BDNF-Abs p < 0.001) when a treatment with BDNF
blocking antibodies was compared to a control treatment or
to a treatment with exogenous BDNF (Figure 1F). Application
of BDNF (gain-of-function experiment) did not result in any
significant alteration in spine head size when compared to the
control conditions (Figure 1F). Binning the spines according
to their length did not show any difference for BDNF treated
neurons but resulted in a significant alteration in spine length
distribution upon BDNF antibody treatment (loss-of-function)
(Figure 1G). While under these conditions spines shorter than
1.5μmwere significantly decreased (Figure 1G; ≥0.5μm <1μm
p < 0.01 to the BDNF treatment; ≥1μm <1.5μm p < 0.05 to
the control), those longer that 1.5μmwere significantly increased
when compared to the control conditions or the BDNF treatment
(Figure 1G; p < 0.01 to the control, p < 0.001 to BDNF treat-
ment). Finally, the effects of either a gain- or a loss-of-function for
BDNF on dendritic architecture were analyzed using a Sholl anal-
ysis to compare dendritic complexity. No significant differences
in dendritic complexity could be observed between the three
different treatments (Figure 1H; control, BDNF, BDNF-Abs).
Accordingly, also total dendritic complexity was not significantly
different in BDNF or BDNF- antibody-treated cells vs. control
cells (Figure 1H′, Table S1).
Taken together, these results demonstrate that the exogenous
application of BDNF, in mature primary hippocampal neurons,
does not influence dendritic spine density, morphology and
dendrite complexity. On the other hand, the loss-of-function
experiments show that the endogenous BDNF is essential for
maintaining spine density and the mature morphology of den-
dritic spines in primary hippocampal neurons.
ENDOGENOUS BDNF REGULATES DENDRITIC SPINE DENSITY AND
MORPHOLOGY IN DEVELOPING PRIMARY HIPPOCAMPAL NEURONS
In the next series of experiments we tested whether the dif-
ferent effects of exogenous vs. endogenous BDNF on neuronal
structure might depend on the age of the treated primary hip-
pocampal neurons. To this aim we analyzed whether a gain- or
a loss-of-function approach for BDNF regulates the dendritic
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FIGURE 1 | (A) Experimental timeline. DIV23 hippocampal neurons were
treated for 24 h before fixation. (B) Representative image of a typical DIV23
fEGFP expressing hippocampal neuron used in the experiments; the inserts
on the right show a close up of the cell body labeled with fEGFP (above) or
with an immunohistochemistry against CaMKII (middle) merged to show
colocalization (below): scale bars are 50μm. (B′) High-magnification image of
typical dendritic stretches from control (left), BDNF (middle) and BDNF
(Continued)
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FIGURE 1 | Continued
antibodies (right) treated neurons. Scale bar, 5μm. (C) Graphs comparing
dendritic spine density between BSA (control), BDNF and BDNF antibodies
(BDNF-Abs) treated DIV22 hippocampal neurons. (D)Histogram comparing the
spine head width between hippocampal neurons upon BSA (control), BDNF or
BDNF antibodies (BDNF-Abs) treatment. (E) Histogram of the dendritic spine
length in control, BDNF or BDNF antibodies (BDNF-Abs) treated neurons. (F)
Graph showing the binning of spines according to their spine head width and
comparing the proportion of spines within each category in response to a BSA
(control), BDNF or BDNF antibodies (BDNF-Abs) treatment. (G) Graph
showing the binning of spines according to their spine length and comparing
the proportion of spines within each category in response to a BSA (control),
BDNF or BDNF antibodies (BDNF-Abs) treatment. (H) Graph plotting dendritic
complexity in relation to the distance to the cell body of hippocampal neurons
under control conditions or treated with BDNF or BDNF antibodies
(BDNF-Abs). (H′) Histogram of the total number of intersections for BSA
(control), BDNF and BDNF antibodies (BDNF-Abs) treated neurons. The
number in the columns represents the number of cells analyzed. Significance
is indicated as follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Error bars indicate
s.e.m. ANOVA, post-hoc Tukey’s Multiple Comparison Test.
architecture or spine number andmorphology in 2 weeks-old pri-
mary hippocampal neurons (15DIV; Figure 2A). When 15DIV
fEGFP-expressing neurons treated for 24 hours with BDNF were
compared to control neurons, no obvious difference in dendritic
spine density or morphology could be observed. Accordingly, the
quantification of spine density did not result in any significant dif-
ference between BDNF treated and control neurons (Figure 2B,
Table S1). However, as formature hippocampal neurons, also here
the application of BDNF blocking antibodies led to a highly sig-
nificant reduction in dendritic spine density (Figure 2B, Table S1;
control vs. BDNF-Abs and BDNF vs. BDNF-Abs p < 0.001). We
then assessed whether BDNF regulates spine morphology com-
paring the maximal spine head width and spines length between
different treatments. Application of exogenous BDNF for 24 h
did not result in any significant alteration of the spine head
width (Figure 2C, Table S1) and length (Figure 2D, Table S1) in
comparison to the control condition. Interestingly, while the loss-
of-function experiments did not result in any significant change
in spine head width (Figure 2C, Table S1) a significant increase
in dendritic spine length could be observed after application of
BDNF blocking antibodies in comparison to both the control and
the BDNF treatment (Figure 2D, Table S1; control vs. BDNF-
Abs and BDNF vs. BDNF-Abs p < 0.001). Binning the spines
according to their head width and comparing the different treat-
ments within each spine head category resulted in a significant
increase in the proportion of spines with a small head for the
BDNF blocking antibody treatment only when compared to the
BDNF treatment (Figure 2E; BDNF vs. BDNF-Abs p < 0.05). No
significant changes could be observed for the spine head width
distribution upon BDNF application (Figure 2E) when compared
to the control condition. Binning the spines according to their
length showed for neurons treated with BDNF blocking antibod-
ies a significant decrease in the shorter spine category (Figure 2F;
<0.5μm, control vs. BDNF-Abs p < 0.01, BDNF vs. BDNF-Abs
p < 0.001; and≥0.5μm<1μm, control vs. BDNF-Abs p < 0.01,
BDNF vs. BNF-Abs p < 0.001) accompanied by a significant
increase in longer spines (Figure 2F;>1.5μm, control vs. BDNF-
Abs p < 0.01, BDNF vs. BDNF-Abs p < 0.001). Finally, we also
analyzed whether the effect of BDNF on dendrite architecture
might be age dependent. However, also for 15DIV hippocampal
neurons when either a BDNF or a BDNF antibody treatment was
compared to the controls, no significant alteration in dendritic
complexity could be observed for the Sholl analysis (Figure 2G).
Accordingly, we did not observe any significant differences in
total complexity between the different treatments (Figure 2G′,
Table S1).
All in all the results described above indicate that endoge-
nous BDNF is necessary for dendritic spine growth and to
regulate spine length in developing primary hippocampal neu-
rons. Interestingly, the spine head width in younger hippocampal
neurons is not dependent on endogenous BDNF signaling.
ENDOGENOUS BDNF REGULATES ACTIN CONCENTRATION WITHIN
DENDRITIC SPINE
Because the actin cytoskeleton is involved in regulating cell mobil-
ity and morphology and actin is highly enriched within the
dendritic spine head—for a review see (Cingolani and Goda,
2008)—we hypothesized that BDNF may regulate actin in den-
dritic spines in order to shape and change spine morphology. To
test this hypothesis we used RFP-Lifeact (Riedl et al., 2008 and
2010) to detect possible changes in the F-actin content in den-
dritic spines upon changes in BDNF signaling. The RFP-Lifeact
expression plasmid was co-transfected with fEGFP and resulted in
99.7% colocalization of RFP-Lifeact within spines (Figures 3A/B)
as well as with F-actin labeled using Alexa Fluor 350 Phalloidin
(Figure 3B). In line with our observations the exogenous applica-
tion of BDNF for 24 hours to 22 or 15DIV primary hippocampal
neurons did not result in any change in the normalized mean
fluorescent intensity for RFP-Lifeact in comparison to control
(Figures 3C,D, Table S1). However, in the loss-of-function exper-
iments the treatment with BDNF blocking antibodies resulted
in a highly significant decrease in the F-actin content within
the head of dendritic spines both in 16DIV (Figure 3D, Table
S1; control vs. BDNF-Abs p < 0.001, BDNF vs. BDNF-Abs p <
0.001) and 23DIV primary hippocampal neurons (Figure 3D,
Table S1; control vs. BDNF-Abs p < 0.01, BDNF vs. BDNF-Abs
p < 0.001).
Taken together our results show that endogenous BDNF mod-
ulates the actin cytoskeleton within dendritic spines as well as
their morphology.
MATURE PRIMARY HIPPOCAMPAL NEURONS ARE RESPONSIVE TO AN
ACUTE TREATMENT WITH EXOGENOUS BDNF
Our results so far clearly support a role for endogenous BDNF
in the hippocampus by completely reproducing in vitro the mild
alterations observed in the morphology of hippocampal neu-
rons in vivo upon a global BDNF deprivation (Rauskolb et al.,
2010). On the other hand our data fail to replicate previous work
showing an effect of BDNF application in regulating dendrite
and spine architecture (Tyler and Pozzo-Miller, 2001; Ji et al.,
2005). To address this discrepancy we first confirmed that the
BDNF used in this study is indeed active and that it is able
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FIGURE 2 | (A) Experimental timeline. DIV16 hippocampal neurons were
treated for 24 h before fixation (B) Graphs comparing dendritic spine density
between control, BDNF and BDNF-antibodies (BDNF-Abs) treated DIV16
hippocampal neurons. (C) Histogram comparing the spine head width
between hippocampal neurons upon BSA (control), BDNF or BDNF
antibodies treatment. (D) Histogram of the dendritic spine length in BSA
(control), BDNF or BDNF antibodies (BDNF-Abs) treated neurons. (E) Graph
showing the binning of spines according to their spine head width and
comparing the proportion of spines within each category in response to a
BSA (control), BDNF or BDNF antibodies (BDNF-Abs) treatment. (F) Graph
showing the binning of spines according to their spine length and comparing
the proportion of spines within each category in response to a BSA (control),
BDNF or BDNF antibodies (BDNF-Abs) treatment. (G) Graph plotting dendritic
complexity in relation to the distance to the cell body of hippocampal neurons
under control conditions or treated with BDNF or BDNF antibodies
(BDNF-Abs). (G′) Histogram of the total number of intersections for BSA
(control), BDNF and BDNF antibodies (BDNF-Abs) treated neurons. The
number in the columns represents the number of cells analyzed. Significance
is indicated as follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Error bars
indicate s.e.m. ANOVA, post-hoc Tukey’s Multiple Comparison Test.
to elicit clear neuronal responses in primary hippocampal neu-
ronal cultures. To this aim we tested three critical events known
to occur upon a BDNF application: (a) activation of the TrkB
receptor was tested by analyzing its phosphorylation levels (Ji
et al., 2010); (b) calcium imaging was used to test the ability of
BDNF to induce local calcium transients in hippocampal neurons
(Berninger et al., 1993) and (c) immunohistochemistry was used
to visualize the activation of the immediate early gene (IEG) c-fos
(Marty et al., 1996). An immunohistochemistry against phospho-
rylated TrkB receptor performed 15min after BDNF application
(Figure 4A) showed an obvious increase in the levels of TrkB
receptor phosphorylation when compared to control treated neu-
rons (Figure 4B). This observation was confirmed by a signifi-
cant increase in the normalized intensity for the phospho-TrkB
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FIGURE 3 | (A)Maximal intensity projection of a representative dendrite of
hippocampal neurons expressing fEGFP (above) and RFP-Lifeact (middle)
merged to show colocalization (below). Scale bar, 2μm. (B)Highmagnification
images showing a single dendritic spine expressing fEGFP (above) and
RFP-Lifeact (middle) and merged to show their colocalization in the spine head
(below)Scalebar, 2μm. (C)Histogramplotting thenormalizedmeanfluorescent
intensity for RFP-Lifeact within the spine head of DIV23 BSA (control), BDNF
and BDNF antibodies (BDNF-Abs) treated neurons. (D)Histogram showing the
normalized mean intensity for RFP-Lifeact within the spine head of DIV16
hippocampal neurons. The number in the columns represents the number of
cells analyzed. Significance is indicated as follows: ∗∗p < 0.01; ∗∗∗p < 0.001.
Error bars indicate s.e.m. ANOVA, post-hoc Tukey’s Multiple Comparison Test.
immunohistochemistry (Figure 4C, Table S2; p < 0.001) as well
as by a clear shift in the proportion of positive vs. negative cells for
phospho-TrkB. Indeed, upon BDNF treatment significantly more
neurons resulted to be positive for phospho-TrkB immunohisto-
chemistry and significantly less to be negative for it (Figure 4D,
Table S2; p < 0.01). The activation of the PLCγ signaling path-
way upon BDNF binding to the TrkB receptor leads to an increase
in the intracellular calcium levels (Segal and Greenberg, 1996;
Blum and Konnerth, 2005; Minichiello, 2009) and was specifically
shown for hippocampal cultures (Berninger et al., 1993; Canossa
et al., 1997; Finkbeiner et al., 1997). Here we analyzed the fre-
quency of global calcium transients as readout for a neuronal
response to an acute BDNF application (Figure 4E; Lang et al.,
2007; Lohmann, 2009). A clear increase in the frequency of cal-
cium transients in DIV22 primary hippocampal neurons could
be observed upon the acute application of BDNF (Figure 4F).
Indeed, at a quantitative analysis calcium transient frequency
resulted to be significantly increased after BDNF treatment in
comparison to a control treatment (Figure 4G, Table S2; BDNF
vs. control p < 0.05). The increase in the frequency in calcium
transients upon BDNF application was transient as 10min after
BDNF washout the frequency was back to the pre-treatment
levels (Figure 4G, Table S2). Finally, to verify that the applica-
tion of BDNF leads to the expression of immediate early genes
(IEGs) we used an immunohistochemistry for c-fos known to
be activated upon an acute treatment with BDNF (Figure 4H;
Marty et al., 1996; Gascon et al., 2005). An immunohistochem-
istry for c-fos showed a clear colocalization between c-fos and
the nucleus of neurons (Figure 4E). Quantitative analysis per-
formed 3 h after the stimulation with BDNF (Figure 4H) showed
significantly higher intensity values for the c-fos immunohis-
tochemistry (Figure 4J, Table S2; p < 0.01) and a significant
increase in the number of c-fos positive cells in comparison to
control (Figure 4K, Table S2; p < 0.001).
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FIGURE 4 | (A) Experimental timeline. DIV22 primary hippocampal neurons
were treated 15min with BDNF before fixation. (B) Images of primary
hippocampal cultures (22DIV) treated with either BSA (control) (left) or
BDNF (right) and stained with an anti-phospho-TrkB receptor antibodies.
Scale bar, 40μm. (C) Histogram showing the normalized fluorescence
intensity for the phospho-TrkB receptor under control conditions or treated
with BDNF. (D) Graph showing the number of phospho-TrkB positive
hippocampal neurons in control and BDNF treated hippocampal primary
cultures. (E) Experimental timeline. DIV22 primary hippocampal neurons
were treated 5min with BDNF during calcium imaging. (F) Pseudo line-scan
showing the global calcium transients occurring in hippocampal primary
cultures before, during and after BDNF applications. (G) Graph showing
the frequency of calcium transients in hippocampal primary neurons
before, during and after BDNF application. (H) Experimental timeline.
DIV22 primary hippocampal neurons were treated for 3 h with BDNF
before fixation. (I) Images of primary hippocampal cultures (22DIV) treated
with either BSA (control) (above) or BDNF (below) and stained with an
anti-c-fos antibody. Scale bar, 20μm. (J) Graph comparing the normalized
mean intensity for the immunohistochemistry against c-fos in control or
BDNF treated hippocampal primary neurons. (K) Histogram of the number
of c-fos positive neurons in control and BDNF treated hippocampal
cultures. The number in the columns represents the number of analyzed
experiments. Significance is indicated as follows: ∗p < 0.05; ∗∗p < 0.01;
∗∗∗p < 0.001. Error bars indicate s.e.m. Unpaired two-tailed Student Test.
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In summary we could show that the BDNF used in these exper-
iments is active and clearly leads to an activation of the TrkB-
receptor, an increase in the frequency of calcium transients and an
activation of transcription (up regulation of the immediate early
gene c-fos) in mature primary hippocampal neurons.
EXOGENOUS BDNF REGULATES NEURITE OUTGROWTH AND
COMPLEXITY IN YOUNG PRIMARY HIPPOCAMPAL NEURONS
Previous studies have shown BDNF to promote neurite outgrouth
and dendritic complexity (Mcallister et al., 1995; Shimada et al.,
1998). In view of the lack of effects on dendritic architecture
observed in this study upon BDNF application to either DIV15
or DIV22 hippocampal primary neurons, we tested whether the
effect of BDNF on dendrites might be age-dependent. Indeed,
BDNF has been shown to regulate neurite outgrowth in develop-
ment hippocampal neurons (Ji et al., 2005, 2010). Therefore, we
treated young hippocampal neurons 3DIV with either a gain- or
a loss-of-function approach for BDNF. After 3 days of treat-
ment (Figure 5A) an immunohistochemistry for Microtubule-
associated protein 2 (MAP2) was used to visualize the developing
neurites (Figure 5B; up control, middle BDNF, lower TrkB-Fc).
Morphometric analysis for neurite growth was performed by
quantifying three parameters: total neurite length, number of pri-
mary neurites and number of branching points (Figures 5C–E,
Table S3). The total neurite length was higher after BDNF applica-
tion than in control treated neurons (Figure 5C, Table S3; BDNF
vs. control, p < 0.001). Interestingly the loss-of-function exper-
iments with either a BDNF-Abs or TrkB-Fc did not show any
significant difference in neurite length when compared to the con-
trol conditions (Figure 5C, Table S3). The specificity of the TrkB-
Fc in neutralizing BDNF was determined by a co-application of
BDNF and TrkB-Fc. Quantitative analysis revealed that appli-
cation of TrkB-Fc completely prevented the positive effect of a
BDNF treatment on the total neurite length (Figure 5C, Table S3).
The number of primary neurites after BDNF application showed
a slight increase when compared to the control (Figure 5D, Table
S3; BDNF vs. control, p < 0.01), whereas the treatment with
BDNF-Abs or TrkB-Fc did not alter neurite number (Figure 5D,
Table S3). The significant increase in primary neurites observed
after BDNF treatment could be prevented by a co-treatment with
TrkB-Fc (Figure 5D, Table S3). Next we determined whether a
BDNF application might affect neurite complexity by analyz-
ing the number of branching points of MAP2 labeled processes.
Indeed, a BDNF treatment resulted in a 2-fold increase in com-
plexity in comparison to control (Figure 5E, Table S3; BDNF vs.
control, p < 0.001). On the contrary, treatment with BDNF-Abs
or TrkB-Fc did not influence the number of branching points
when compared to the control (Figure 5E, Table S3). Additionally,
the positive effect of BDNF on neurite complexity was pre-
vented by a co-treatment with BDNF and TrkB-Fc (Figure 5E,
Table S3).
Our results suggest that the application of BDNF promotes
neurite outgrowth by increasing both neurite elongation and
branching in developing DIV3 hippocampal primary neurons.
Interestingly, two loss-of-function approaches for BDNF did not
affect the neurite architecture of primary hippocampal neurons
(3–6DIV) during their early development.
ROLE OF NEURONAL ACTIVITY IN REGULATING THE SENSITIVITY OF
MATURE HIPPOCAMPAL NEURONS UPON EXOGENOUS BDNF
APPLICATION
BDNF synthesis and release have been shown to occur in an
activity-dependent way (Thoenen, 1991; Gärtner and Staiger,
2002). Therefore, one possible explanation for the discrepan-
cies in the effect of BDNF application on neuronal morphology
in vitro (Ji et al., 2005, 2010; Rauskolb et al., 2010) may lie
in the different levels of neuronal activity in the primary cul-
tures. Indeed, in cultures with a higher neuronal activity the
levels of endogenous BDNF may be already high and might mask
the effects of BDNF application. To test this hypothesis primary
hippocampal neurons were kept for 2 weeks in a medium con-
taining a higher concentration of Magnesium (3.5mM Mg2+;
Figure 6A) and the effects of a 24 h treatment with BDNF (in
NB medium with low, 1.5mM Mg2+) on the number and
structure of dendritic spines were analyzed. Calcium imaging
was used to compare the levels of neuronal activity in hip-
pocampal neurons grown under high Mg2+ to those of neurons
grown under control (low Mg2+) conditions. While no signif-
icant difference could be detected regarding the amplitude of
global calcium transients between the two groups (Figure 6C,
Table S4), their frequency was significantly decreased in neu-
rons kept in high Mg2+ when compared to control neurons
(Figure 6B, Table S4; p < 0.001) suggesting a long-term reduc-
tion in neuronal activity. Accordingly, while dendritic complex-
ity was unchanged (Figure 6D, Table S4), a significantly lower
dendritic spine density could be observed when comparing con-
trol neurons kept in high Mg2+ with control neurons kept in
low Mg2+ medium (Figure 6E, Table S4; p < 0.001). On the
other hand, no significant differences in spine density could
be detected upon a BDNF or a TrkB-Fc treatment for neu-
rons grown under high Mg2+ conditions when compared to
the control high Mg2+ conditions (Figure 6E, Table S4). Next,
a possible effect of BDNF on dendritic spine morphology was
analyzed. Interestingly, compared to control treated neurons
BDNF treatment in cultures kept in high Mg2+ resulted in a
slight increase in dendritic spine width (Figure 6F, Table S4)
and a slight decrease in spine length (Figure 6G, Table S4), but
the difference did not reach significance. No significant differ-
ences were observed both for the head width and for the length
when TrkB-Fc treated cells in high Mg2+ were compared to
high Mg2+ controls (Figures 6F,G, Table S4). To better clarify
the mild spine head increase observed in neurons kept in high
Mg2+ medium upon BDNF treatment spines were binned into
four categories according to their head width. Comparing spine
head width within each category showed a significant increase
upon BDNF treatment in the proportion of spines with larger
heads (Figure 6H; ≥0.5μm <1μm; p < 0.05) with a compa-
rable significant decrease in the proportion of spine with small
heads (Figure 6H; <0.3μm; p < 0.05) when compared to con-
trol neurons cultivated in high Mg2+. No significant difference
was observed between the control and TrkB-Fc treatments in any
of the spine head width categories under the same conditions
(Figure 6H). Comparing the effect of a control, a BDNF or a
TrkB-Fc treatment within different categories of dendritic spine
binned according to their length did not show any significant
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FIGURE 5 | (A) Experimental timeline. BSA, BDNF, BDNF antibodies
(BDNF-Abs) or TrkB receptor bodies (TrkB-Fc) were applied on DIV3
hippocampal neurons for 72 h. (B) Micrographs showing MAP2 positive BSA
(control) (above), BDNF (middle) or BDNF antibodies (BDNF-Abs; below)
treated primary hippocampal neurons. Scale bar, 25μm. (C) Histogram
comparing neurite length of DIV6 hippocampal neurons after application of
BSA (control), BDNF, BDNF antibodies (BDNF-Abs), TrkB receptor bodies
(TrkB-Fc) or combined BDNF and TrkB receptor bodies (TrkB-Fc). (D)
Histogram comparing the number of primary neurites of DIV6 hippocampal
neurons after application of BSA (control), BDNF, BDNF antibodies
(BDNF-Abs), TrkB receptor bodies (TrkB-Fc) or combined BDNF and TrkB
receptor bodies (TrkB-Fc). (E) Histogram comparing the number of branching
points for the dendrites of DIV6 hippocampal neurons after application of BSA
(control), BDNF, BDNF antibodies (BDNF-Abs), TrkB receptor bodies (TrkB-Fc)
or combined BDNF and TrkB receptor bodies (TrkB-Fc). The number in the
columns represents the number of cells analyzed. Significance is indicated as
follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Error bars indicate s.e.m.
ANOVA, post-hoc Tukey’s Multiple Comparison Test.
difference (Figure 6I). The data described above suggest that
indeed a chronic reduction in neuronal activity during the cul-
tivation time might reduce the endogenous BDNF levels in hip-
pocampal primary neurons and thereby increase their sensitivity
to an exogenous BDNF application to modulate dendritic spine
morphology.
THE ACTION OF EXOGENOUS BDNF IN MODULATING DENDRITIC
SPINE MORPHOLOGY DEPEND ON NEURONAL ACTIVITY
BDNF has been shown to modulate dendritic spine morphol-
ogy upon activity-dependent synaptic plasticity Tanaka (Tanaka
et al., 2008). To assess whether under our culture condition
neuronal activity governs the BDNF effect on dendritic spine
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FIGURE 6 | (A) Experimental timeline. Primary neurons were cultivated for 2
weeks in high (3.5mM)Mg2+ medium and treatedwith BSA (control), BDNF or
TrkB-Fc in low (1.5mM)Mg2+. (B)Graph comparing the frequency of calcium
transients in hippocampal primary neurons cultivated in high or lowMg2+
containingmedium. (C)Graph comparing the amplitude of calcium transients in
hippocampal primary neurons cultivated in high or lowMg2+ containing
medium. (D)Histogram of the total number of intersections in hippocampal
primary neurons cultivated in high or lowMg2+ containing medium. (E)Graphs
comparing dendritic spine density between neurons cultivated in low or high
Mg2+ and treatedwith BSA (control), BDNF and TrkB receptor bodies (TrkB-Fc).
(F)Histogram comparing the spine head width between primary hippocampal
neurons cultivated in highMg2+ and treatedwith BSA (control), BDNF and TrkB
receptor bodies (TrkB-Fc). (G)Histogram of the dendritic spine length between
primary hippocampal neurons cultivated in highMg2+ and treated with BSA
(control), BDNF and TrkB receptor bodies (TrkB-Fc). (H)Graph showing the
binning of spines according to their spine head width and comparing the
proportion of spines within each category in response to a BSA (control), BDNF
or BDNF antibodies (BDNF-Abs) treatment. (I)Graph showing the binning of
spines according to their spine length and comparing the proportion of spines
within each category in response to a control, BDNF or TrkB receptor bodies
(TrkB-Fc) treatment. The number in the columns represents the number of cells
analyzed. Significance is indicated as follows: ∗p < 0.05; ∗∗∗p < 0.001. Error
bars indicate s.e.m. Unpaired two-tailed Student Test and ANOVA, post-hoc
Tukey’s Multiple Comparison Test.
morphology, hippocampal primary neurons were kept for 2
weeks and treated with BDNF in a high Mg2+ (3.5mM) medium
(Figure 7A) in order to reduce neuronal activity. Under these
conditions a significantly lower dendritic spine density could
be observed when comparing control neurons kept in high
Mg2+ to control neurons in low Mg2+ medium (Figure 7B,
Table S4; p < 0.05). Moreover, dendritic spine density of neu-
rons treated either with BDNF or with TrkB-Fc in high Mg2+
was significantly lower than in controls (low Mg2+) neurons
(Figure 7B, Table S4; BDNF vs. low Mg2+ control p < 0.05;
TrkB-Fc vs. low Mg2+ control p < 0.001). Interestingly, both
a BDNF treatment as well as a treatment with TrkB-Fc per-
formed in high Mg2+ did not affect either spine head width
(Figure 7C, Table S4) or spine length (Figure 7D, Table S4)
when compared to a control treatment in high Mg2+. Also
binning the spines according to their head width (Figure 7E)
or to their length (Figure 7F) did not show any alteration in
the spine size distributions both for a BDNF and a TrkB-Fc
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FIGURE 7 | (A) Experimental timeline. Primary neurons were cultivated for 2
weeks in high Mg2+ medium and treated with BSA (control), BDNF or
TrkB-Fc in high Mg2+. (B) Graphs comparing dendritic spine density between
neurons cultivated in low or high Mg2+ and treated with BSA (control), BDNF
and TrkB receptor bodies (TrkB-Fc) in high Mg2+. (C) Histogram comparing
the spine head width between primary hippocampal neurons cultivated and
treated in high Mg2+ with BSA (control), BDNF and TrkB receptor bodies
(TrkB-Fc). (D) Histogram of the dendritic spine length between primary
hippocampal neurons cultivated and treated in high Mg2+ with BSA (control),
BDNF and TrkB receptor bodies (TrkB-Fc). (E) Graph showing the binning of
spines according to their spine head width and comparing the proportion of
spines within each category in response to a BSA (control), BDNF or BDNF
antibodies (BDNF-Abs) treatment in high Mg2+. (F) Graph showing the
binning of spines according to their spine length and comparing the
proportion of spines within each category in response to a BSA (control),
BDNF or TrkB receptor bodies (TrkB-Fc) treatment in high Mg2+. The number
in the columns represents the number of cells analyzed. Significance is
indicated as follows: ∗p < 0.05; ∗∗∗p < 0.001. Error bars indicate s.e.m.
Unpaired two-tailed Student Test and ANOVA, post-hoc Tukey’s Multiple
Comparison Test.
applications compared to a control treatment performed in
high Mg2+.
The results above indicate that BDNF application indeed
modulates dendritic spine architecture in an activity-dependent
manner.
DISCUSSION
The main findings in this study are that the effects exerted by
BDNF on the dendritic architecture of hippocampal neurons are
dependent on the neuron’s maturation stage and that BDNF is
specifically required for the activity-dependent maintenance of
the mature spine phenotype in mature excitatory hippocampal
neurons in vitro. Indeed, our current results reproduce previous
results obtained in vivo (Rauskolb et al., 2010). These observa-
tions further support the notion, that BDNF is a precise mediator
of specific effects on neurons rather than a pleiotropic molecule
unspecifically promoting cell health and survival. Indeed, besides
its role in promoting neurite outgrowth (Ji et al., 2005, 2010),
which we can confirm in the data presented here, BDNF is
required for the activity-dependent maturation and stabilization
of dendritic spines.
Our results are in line with previous work showing a surprising
selectivity in the brain areas requiring BDNF-signaling for nor-
mal post-natal development (Minichiello et al., 1999; Zakharenko
et al., 2003; Rauskolb et al., 2010; Zagrebelsky and Korte, 2013).
Indeed, while a global BDNF deprivation throughout the CNS
impairs the proper post-natal growth of striatal medium spiny
neurons, BDNF deprivation fails to cause major alterations in the
fine structure of mature CA1 pyramidal neurons (Rauskolb et al.,
2010). These observations suggest a crucial but rather limited
and specific effect of BDNF in maintaining the mature pheno-
type of dendritic spines without affecting the general architecture
of hippocampal neurons. Our results in vitro show a very similar
effect upon the application of two loss-of-function approaches for
BDNF (function blocking BDNF antibodies, TrkB receptor bod-
ies) confirming a physiological role of the endogenous BDNF in
this context. On the other hand, our experiments fail to reproduce
previously published data showing a highly significant increase
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in dendritic spine density and alterations in spine morphology
upon the application of exogenous BDNF to mature hippocam-
pal primary neurons (Ji et al., 2005, 2010) or to hippocampal slice
cultures (Tyler and Pozzo-Miller, 2001). The discrepancy between
the data presented here and other previously published data
regarding the role of exogenous BDNF in regulating the architec-
ture of mature hippocampal neurons may have different reasons.
One possible explanation is the different animal species used for
the experiments. While studies showing an effect of a BDNF loss-
of-function either in vivo (Rauskolb et al., 2010) or in vitro (our
current study) were mostly performed in mouse derived cultures,
most of the previous in vitrowork describing an effect for a BDNF
gain-of-function was done in rat hippocampal neurons (Tyler and
Pozzo-Miller, 2001; Ji et al., 2005, 2010) suggesting a possible dif-
ference in the sensitivity to BDNF signaling in the two different
species—or simply a different level of BDNF release from neu-
rons into the medium. Moreover, culture conditions have been
shown to possibly influence the expression levels as well as the cel-
lular response to BDNF (Chapleau et al., 2008). Indeed, here we
show that the levels of neuronal activity in the cultures determine
the responsiveness to the exogenous or the endogenous BDNF
(Figures 6, 7). Low levels of neuronal activity during the cultiva-
tion period result in lower spine density values and an increased
responsiveness of the hippocampal neurons to the applications of
exogenous BDNF. Indeed, the synthesis and secretion of BDNF
have been shown to be directly controlled by neuronal activity
(reviewed in Thoenen, 1991; see also Gärtner and Staiger, 2002).
Accordingly, control neurons in previous publications showing
a strong effect upon a BDNF application (Ji et al., 2005, 2010)
had a spine density which is about 10 times smaller than the one
measured in the current study or described in vivo (De Simoni
et al., 2003) and 5 times smaller than the one described for a more
complex in vitro system (De Simoni et al., 2003; Rauskolb et al.,
2010). It should also be noted that in our culture system the lev-
els of neuronal activity as well as the cellular responsiveness to
BDNF were tested in different ways (Figures 4A–K). Application
of exogenous BDNF has been shown to trigger a direct response
of the neuronal network via a transient elevation of the intracel-
lular calcium concentration (Berninger et al., 1993; Lang et al.,
2007). In contrast, blocking intrinsic BDNF signaling was shown
to reduce the frequency of spontaneously occurring calcium rises
in developing rat hippocampal neurons (Lang et al., 2007). In
our study calcium imaging was used first to test the responsive-
ness of the hippocampal neurons to BDNF and also to test the
effects on neuronal activity of manipulating the Mg2+ concen-
tration in the culture medium. Thereby we could confirm that
increasing Mg2+ concentration in the medium results in a long
lasting reduction in neuronal excitability and network activity
of primary hippocampal cultures (Dribben et al., 2010). While
this reduction in neuronal activity does not influence dendritic
morphology and complexity, it’s accompanied by a significant
decrease in dendritic spine density as well as by an increased
cellular sensitivity to the application of exogenous BDNF. The
cellular responsiveness to BDNF was tested also quantifying the
changes in TrkB phosphorylation as well as the activation of the
IEG c-fos, two critical events known to occur upon the acute
activation of BDNF signaling (Marty et al., 1996; Ji et al., 2005,
2010). Our results indicate that in spite of the lack of mor-
phological effects of an application of BDNF, mature excitatory,
hippocampal neurons under the culture conditions used in this
work are responsive to BDNF. In addition, their responsiveness
is increased under low neuronal activity conditions. Whether the
increase neuronal responsiveness to BDNF is due to an activity-
dependent decrease in BDNF release from neurons or, as recently
described from microglia (Parkhurst et al., 2013) will be very
interesting to address. Indeed, changes in magnesium concentra-
tion have been shown to possibly influence ATP release (Li et al.,
1997) and could thereby indirectly influence BDNF release from
microglia (Trang et al., 2009; Parkhurst et al., 2013). Moreover,
it will be crucial to explore the possibility that different amounts
of microglia may influence the BDNF levels in the primary hip-
pocampal cultures and thereby their responsiveness to a BDNF
exogenous application.
Our results show a requirement for neuronal-activity during
the application for BDNF to exert its effect on dendritic spines.
This observation is in line with previous work showing that dur-
ing the early development of cortical pyramidal neurons in ferrets
BDNF regulates dendritic architecture in an activity-dependent
manner (Mcallister et al., 1996). Moreover, in cultures of cere-
bellar neurons, BDNF increases the spine density of Purkinje
cells only in the presence of granule cells suggesting a crucial
role of neuronal activity in mediating this BDNF effect (Shimada
et al., 1998). In line with this observation is the role of BDNF in
regulating structural changes at dendritic spines upon activity-
dependent synaptic plasticity in mature hippocampal neurons
(Tanaka et al., 2008).
One important open question concerns the functional
consequences of the observed structural changes at spines reg-
ulated by BDNF signaling. Our results upon a BDNF loss-of-
function confirm the structural alterations at spine observed
already in vivo (Rauskolb et al., 2010). Specifically, a BDNF
deprivation results in a decrease in dendritic spine density accom-
panied by a decrease in spine head width and an increase in
spine length suggesting a loss of the mature phenotype of spines
possibly resulting in a decrease and a weakening of synaptic
connections under these conditions. Indeed, spine head width
is correlated with the size of the post-synaptic density and the
number of AMPA receptors (Holtmaat and Svoboda, 2009) and
a shrinking of the spine head width has been correlated to the
synaptic weakening occurring upon long term depression induc-
tion (Zhou et al., 2004). Moreover, the spine neck has been
suggested to act as a diffusion barrier regulating the biochem-
ical compartmentalization in the spine head (Sjostrom et al.,
2008; Holthoff et al., 2010). Indeed, spines with long necks
have been shown to be electrically silent at the soma, although
their heads are activated by an uncaging event (Araya et al.,
2006) and a BDNF-dependent shortening of the spine neck was
observed upon inducing long term potentiation at single spines
(Tanaka et al., 2008). It has been show that upon maturation
the proportion of mushroom spines increases while the one
of thin long spines decreases (De Simoni et al., 2003). Taken
together these data suggest that BDNF signaling plays a cru-
cial role in maintaining the mature architecture of dendritic
spines.
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Finally, we show in our experiments that endogenous BDNF
modulates the actin cytoskeleton within dendritic spines as well
as their morphology. This is of interest with respect to the fact
that activity-dependent as well as spontaneous structural changes
of dendritic spines are dependent on the modulation of actin
dynamics within spines (Krucker et al., 2000; Fukazawa et al.,
2003; Kramar et al., 2004). Noteworthy in this context is the
observation that BDNF modulates actin regulatory binding pro-
teins which control the turnover of the actin cytoskeleton as well
as cytoskeleton-associated proteins like Arc/Arg3.1 (Ying et al.,
2002; Messaoudi et al., 2007; Rex et al., 2007; Bramham, 2008).
Interestingly, while a gain-of-function approach performed in
this study did not affect the F-actin content within dendritic
spines, a loss-of-function experiment resulted in a significant
decrease in polymerized actin (see Figure 3). This is in line with
the results of Rex et al. (2007) which show that exogenous appli-
cation of BDNF to rat hippocampal slices increased the number
of F-actin labeled spines only when theta burst stimulation was
applied (Rex et al., 2007). Moreover, the effect of theta burst stim-
ulation on F-actin was completely abolished by a BDNF scavenger
(TrkB-Fc; Rex et al., 2007) suggesting a role for the TrkB receptor
in this context. On the other hand, BDNF might also modulate
actin dynamics via the p75 Neurotrophin Receptor (p75NTR). In
a series of gain- and loss-of-function experiments we previously
showed that the p75NTR negatively modulates dendritic spine
density and morphology (Zagrebelsky et al., 2005), in addition
to its effect on long-term depression (Rösch et al., 2005; Woo
et al., 2005). It has been shown that signaling via the p75NTR
controls the activity of the small GTPase RhoA, thereby regulat-
ing the actin cytoskeleton (Yamashita et al., 1999; Yamashita and
Tohyama, 2003; Gehler et al., 2004) and possibly preparing it for
processes of negative synaptic plasticity.
In summary our study reports highly specific effects of BDNF
on the maintenance of mature spines in excitatory hippocampal
neurons and it also shed some light on why published in vivo
and in vitro results concerning morphological effects of BDNF are
often contradictory.
ACKNOWLEDGMENTS
We are grateful for the excellent technical assistance of Diane
Mundil. This work was supported by the DFG (Martin Korte and
Marta Zagrebelsky).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://www.frontiersin.org/journal/10.3389/fnsyn.
2014.00005/abstract
REFERENCES
Araya, R., Jiang, J., Eisenthal, K. B., and Yuste, R. (2006). The spine neck fil-
ters membrane potentials. Proc. Natl. Acad. Sci. U.S.A. 103, 17961–17966. doi:
10.1073/pnas.0608755103
Baquet, Z. C., Gorski, J. A., and Jones, K. R. (2004). Early striatal dendrite deficits
followed by neuron loss with advanced age in the absence of anterograde
cortical brain-derived neurotrophic factor. J. Neurosci. 24, 4250–4258. doi:
10.1523/JNEUROSCI.3920-03.2004
Berninger, B., Garcia, D. E., Inagaki, N., Hahnel, C., and Lindholm, D. (1993).
BDNF and NT-3 induce intracellular Ca2+ elevation in hippocampal neurones.
Neuroreport 4, 1303–1306. doi: 10.1097/00001756-199309150-00004
Blum, R., and Konnerth, A. (2005). Neurotrophin-mediated rapid signaling in the
central nervous system: mechanisms and functions. Physiology. (Bethesda) 20,
70–78. doi: 10.1152/physiol.00042.2004
Bramham, C. R. (2008). Local protein synthesis, actin dynamics, and LTP consoli-
dation. Curr. Opin. Neurobiol. 18, 524–531. doi: 10.1016/j.conb.2008.09.013
Canossa, M., Griesbeck, O., Berninger, B., Campana, G., Kolbeck, R., and Thoenen,
H. (1997). Neurotrophin release by neurotrophins: implications for activity-
dependent neuronal plasticity. Proc. Natl. Acad. Sci. U.S.A. 94, 13279–13286.
doi: 10.1073/pnas.94.24.13279
Carreton, O., Giralt, A., Torres-Peraza, J. F., Brito, V., Lucas, J. J., Gines, S., et al.
(2012). Age-dependent decline of motor neocortex but not hippocampal per-
formance in heterozygous BDNF mice correlates with a decrease of cortical
PSD-95 but an increase of hippocampal TrkB levels. Exp. Neurol. 237, 335–345.
doi: 10.1016/j.expneurol.2012.06.033
Chan, J. P., Cordeira, J., Calderon, G. A., Iyer, L. K., and Rios, M. (2008). Depletion
of central BDNF in mice impedes terminal differentiation of new granule
neurons in the adult hippocampus. Mol. Cell. Neurosci. 39, 372–383. doi:
10.1016/j.mcn.2008.07.017
Chan, J. R., Jolicoeur, C., Yamauchi, J., Elliott, J., Fawcett, J. P., Ng, B. K., et al.
(2006). The polarity protein Par-3 directly interacts with p75NTR to regulate
myelination. Science 314, 832–836. doi: 10.1126/science.1134069
Chapleau, C. A., Carlo, M. E., Larimore, J. L., and Pozzo-Miller, L. (2008). The
actions of BDNF on dendritic spine density and morphology in organotypic
slice cultures depend on the presence of serum in culture media. J. Neurosci.
Methods 169, 182–190. doi: 10.1016/j.jneumeth.2007.12.006
Chen, G., Kolbeck, R., Barde, Y. A., Bonhoeffer, T., and Kossel, A. H. (1999).
Relative contribution of endogenous neurotrophins in hippocampal long-term
potentiation. J. Neurosci. 19, 7983–7990.
Cingolani, L. A., and Goda, Y. (2008). Actin in action: the interplay between the
actin cytoskeleton and synaptic efficacy. Nat. Rev. Neurosci. 9, 344–356. doi:
10.1038/nrn2373
Danzer, S. C., Pan, E., Nef, S., Parada, L. F., and Mcnamara, J. O. (2004).
Altered regulation of brain-derived neurotrophic factor protein in hip-
pocampus following slice preparation. Neuroscience 126, 859–869. doi:
10.1016/j.neuroscience.2004.03.025
De Simoni, A., Griesinger, C. B., and Edwards, F. A. (2003). Development of rat
CA1 neurones in acute versus organotypic slices: role of experience in synaptic
morphology and activity. J. Physiol. 550, 135–147. doi: 10.1113/jphysiol.2003.
039099
Dribben, W. H., Eisenman, L. N., and Mennerick, S. (2010). Magnesium induces
neuronal apoptosis by suppressing excitability. Cell Death Dis. 1:e63. doi:
10.1038/cddis.2010.39
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L.,
et al. (2011). Exercise training increases size of hippocampus and improves
memory. Proc. Natl. Acad. Sci. U.S.A. 108, 3017–3022. doi: 10.1073/pnas.
1015950108
Finkbeiner, S., Tavazoie, S. F., Maloratsky, A., Jacobs, K. M., Harris, K. M., and
Greenberg, M. E. (1997). CREB: a major mediator of neuronal neurotrophin
responses. Neuron 19, 1031–1047. doi: 10.1016/S0896-6273(00)80395-5
Fukazawa, Y., Saitoh, Y., Ozawa, F., Ohta, Y., Mizuno, K., and Inokuchi, K. (2003).
Hippocampal LTP is accompanied by enhanced F-actin content within the
dendritic spine that is essential for late LTP maintenance in vivo. Neuron 38,
447–460. doi: 10.1016/S0896-6273(03)00206-X
Gärtner, A., and Staiger, V. (2002). Neurotrophin secretion from hippocampal
neurons evoked by long-term-potentiation-inducing electrical stimulation pat-
terns. Proc. Natl. Acad. Sci. U.S.A. 99, 6386–6391. doi: 10.1073/pnas.0921
29699
Gascon, E., Vutskits, L., Zhang, H., Barral-Moran, M. J., Kiss, P. J., Mas, C., et al.
(2005). Sequential activation of p75 and TrkB is involved in dendritic devel-
opment of subventricular zone-derived neuronal progenitors in vitro. Eur. J.
Neurosci. 21, 69–80. doi: 10.1111/j.1460-9568.2004.03849.x
Gehler, S., Gallo, G., Veien, E., and Letourneau, P. C. (2004). p75 neurotrophin
receptor signaling regulates growth cone filopodial dynamics through modulat-
ing RhoA activity. J. Neurosci. 24, 4363–4372. doi: 10.1523/JNEUROSCI.0404-
04.2004
Genoud, C., Knott, G. W., Sakata, K., Lu, B., andWelker, E. (2004). Altered synapse
formation in the adult somatosensory cortex of brain-derived neurotrophic fac-
tor heterozygote mice. J. Neurosci. 24, 2394–2400. doi: 10.1523/JNEUROSCI.
4040-03.2004
Frontiers in Synaptic Neuroscience www.frontiersin.org March 2014 | Volume 6 | Article 5 | 15
Kellner et al. BDNF effects on dendritic spines
Gorski, J. A., Zeiler, S. R., Tamowski, S., and Jones, K. R. (2003). Brain-derived
neurotrophic factor is required for the maintenance of cortical dendrites.
J. Neurosci. 23, 6856–6865.
Gottmann, K., Mittmann, T., and Lessmann, V. (2009). BDNF signaling in the for-
mation, maturation and plasticity of glutamatergic and GABAergic synapses.
Exp. Brain Res. 199, 203–234. doi: 10.1007/s00221-009-1994-z
He, X. P., Kotloski, R., Nef, S., Luikart, B. W., Parada, L. F., and Mcnamara, J. O.
(2004). Conditional deletion of TrkB but not BDNF prevents epileptogenesis in
the kindling model. Neuron 43, 31–42. doi: 10.1016/j.neuron.2004.06.019
Holthoff, K., Zecevic, D., and Konnerth, A. (2010). Rapid time course of action
potentials in spines and remote dendrites of mouse visual cortex neurons.
J. Physiol. 588, 1085–1096. doi: 10.1113/jphysiol.2009.184960
Holtmaat, A., and Svoboda, K. (2009). Experience-dependent structural synap-
tic plasticity in the mammalian brain. Nat. Rev. Neurosci. 10, 647–658. doi:
10.1038/nrn2699
Hong, E. J., Mccord, A. E., and Greenberg, M. E. (2008). A biological func-
tion for the neuronal activity-dependent component of Bdnf transcrip-
tion in the development of cortical inhibition. Neuron 60, 610–624. doi:
10.1016/j.neuron.2008.09.024
Horch, H. W., Krüttgen, A., Portbury, S. D., and Katz, L. C. (1999). Destabilization
of cortical dendrites and spines by BDNF. Neuron 23, 353–364. doi:
10.1016/S0896-6273(00)80785-0
Ji, Y., Lu, Y., Yang, F., Shen, W., Tang, T. T., Feng, L., et al. (2010). Acute and grad-
ual increases in BDNF concentration elicit distinct signaling and functions in
neurons. Nat. Neurosci. 13, 302–309. doi: 10.1038/nn.2505
Ji, Y., Pang, P. T., Feng, L., and Lu, B. (2005). Cyclic AMP controls BDNF-induced
TrkB phosphorylation and dendritic spine formation in mature hippocampal
neurons. Nat. Neurosci. 8, 164–172. doi: 10.1038/nn1381
Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., and Bonhoeffer, T. (1995).
Hippocampal long-term potentiation is impaired in mice lacking brain-derived
neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 92, 8856–8860. doi: 10.1073/
pnas.92.19.8856
Kramar, E. A., Lin, B., Lin, C. Y., Arai, A. C., Gall, C. M., and Lynch, G. (2004).
A novel mechanism for the facilitation of theta-induced long-term potenti-
ation by brain-derived neurotrophic factor. J. Neurosci. 24, 5151–5161. doi:
10.1523/JNEUROSCI.0800-04.2004
Krucker, T., Siggins, G. R., and Halpain, S. (2000). Dynamic actin filaments are
required for stable long-term potentiation (LTP) in area CA1 of the hippocam-
pus. Proc. Natl. Acad. Sci. U.S.A. 97, 6856–6861. doi: 10.1073/pnas.100139797
Kwon, H. B., and Sabatini, B. L. (2011). Glutamate induces de novo growth
of functional spines in developing cortex. Nature 474, 100–104. doi:
10.1038/nature09986
Lang, S. B., Bonhoeffer, T., and Lohmann, C. (2006). Simultaneous imaging of
morphological plasticity and calcium dynamics in dendrites. Nat. Protoc. 1,
1859–1864. doi: 10.1038/nprot.2006.267
Lang, S. B., Stein, V., Bonhoeffer, T., and Lohmann, C. (2007). Endogenous brain-
derived neurotrophic factor triggers fast calcium transients at synapses in devel-
oping dendrites. J. Neurosci. 27, 1097–1105. doi: 10.1523/JNEUROSCI.3590-
06.2007
Li, C., Peoples, R. W., and Weight, F. F. (1997). Mg2+ inhibition of ATP-activated
current in rat nodose ganglion neurons: evidence that Mg2+ decreases the
agonist affinity of the receptor. J. Neurophysiol. 77, 3391–3395.
Lohmann, C. (2009). Calcium signaling and the development of specific neu-
ronal connections. Prog. Brain Res. 175, 443–452. doi: 10.1016/S0079-6123(09)
17529-5
Luikart, B. W., Nef, S., Virmani, T., Lush, M. E., Liu, Y., Kavalali, E. T., et al. (2005).
TrkB has a cell-autonomous role in the establishment of hippocampal Schaffer
collateral synapses. J. Neurosci. 25, 3774–3786. doi: 10.1523/JNEUROSCI.0041-
05.2005
Marty, S., Berninger, B., Carroll, P., and Thoenen, H. (1996). GABAergic stim-
ulation regulates the phenotype of hippocampal interneurons through the
regulation of brain-derived neurotrophic factor. Neuron 16, 565–570. doi:
10.1016/S0896-6273(00)80075-6
Mayer, M. L., and Westbrook, G. L. (1987). Permeation and block of N-methyl-
D-aspartic acid receptor channels by divalent cations in mouse cultured central
neurones. J. Physiol. 394, 501–527.
Mcallister, A. K., Katz, L. C., and Lo, D. C. (1996). Neurotrophin regulation
of cortical dendritic growth requires activity. Neuron 17, 1057–1064. doi:
10.1016/S0896-6273(00)80239-1
Mcallister, A. K., Lo, D. C., and Katz, L. C. (1995). Neurotrophins regulate dendritic
growth in developing visual cortex. Neuron 15, 791–803. doi: 10.1016/0896-
6273(95)90171-X
Meijering, E., Jacob, M., Sarria, J. C., Steiner, P., Hirling, H., and Unser, M. (2004).
Design and validation of a tool for neurite tracing and analysis in fluorescence
microscopy images. Cytometry A 58, 167–176. doi: 10.1002/cyto.a.20022
Messaoudi, E., Kanhema, T., Soule, J., Tiron, A., Dagyte, G., Da, S. B., et al.
(2007). Sustained Arc/Arg3.1 synthesis controls long-term potentiation con-
solidation through regulation of local actin polymerization in the dentate
gyrus in vivo. J. Neurosci. 27, 10445–10455. doi: 10.1523/JNEUROSCI.2883-
07.2007
Minichiello, L. (2009). TrkB signalling pathways in LTP and learning. Nat. Rev.
Neurosci. 10, 850–860. doi: 10.1038/nrn2738
Minichiello, L., Korte, M., Wolfer, D., Kuhn, R., Unsicker, K., Cestari, V., et al.
(1999). Essential role for TrkB receptors in hippocampus-mediated learning.
Neuron 24, 401–414. doi: 10.1016/S0896-6273(00)80853-3
Monteggia, L. M., Luikart, B., Barrot, M., Theobold, D., Malkovska, I., Nef, S., et al.
(2007). Brain-derived neurotrophic factor conditional knockouts show gender
differences in depression-related behaviors. Biol. Psychiatry 61, 187–197. doi:
10.1016/j.biopsych.2006.03.021
Papa, M., Bundman, M. C., Greenberger, V., and Segal, M. M. (1995).
Morphological analysis of dendritic spine development in primary cultures of
hippocampal neurons. J. Neurosci. 15, 1–11.
Park, H., and Poo, M. M. (2012). Neurotrophin regulation of neural circuit
development and function. Nat. Rev. Neurosci. 14, 7–23. doi: 10.1038/nrn3379
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R. 3rd., Lafaille, J.
J., et al. (2013). Microglia promote learning-dependent synapse formation
through brain-derived neurotrophic factor. Cell 155, 1596–1609. doi: 10.1016/j.
cell.2013.11.030
Psotta, L., Lessmann, V., and Endres, T. (2013). Impaired fear extinction learning in
adult heterozygous BDNF knock-out mice. Neurobiol. Learn. Mem. 103, 34–38.
doi: 10.1016/j.nlm.2013.03.003
Rauskolb, S., Zagrebelsky, M., Dreznjak, A., Deogracias, R., Matsumoto, T., Wiese,
S., et al. (2010). Global deprivation of brain-derived neurotrophic factor in the
CNS reveals an area-specific requirement for dendritic growth. J. Neurosci. 30,
1739–1749. doi: 10.1523/JNEUROSCI.5100-09.2010
Rex, C. S., Lin, C. Y., Kramar, E. A., Chen, L. Y., Gall, C. M., and Lynch, G.
(2007). Brain-derived neurotrophic factor promotes long-term potentiation-
related cytoskeletal changes in adult hippocampus. J. Neurosci. 27, 3017–3029.
doi: 10.1523/JNEUROSCI.4037-06.2007
Riedl, J., Crevenna, A. H., Kessenbrock, K., Yu, J. H., Neukirchen, D., Bista, M., et al.
(2008). Lifeact: a versatile marker to visualize F-actin. Nat. Methods 5, 605–607.
doi: 10.1038/nmeth.1220
Riedl, J., Flynn, K. C., Raducanu, A., Gartner, F., Beck, G., Bosl, M., et al. (2010).
Lifeact mice for studying F-actin dynamics. Nat. Methods 7, 168–169. doi:
10.1038/nmeth0310-168
Rios, M., Fan, G., Fekete, C., Kelly, J., Bates, B., Kuehn, R., et al. (2001).
Conditional deletion of brain-derived neurotrophic factor in the postnatal
brain leads to obesity and hyperactivity. Mol. Endocrinol. 15, 1748–1757. doi:
10.1210/mend.15.10.0706
Rösch, H., Schweigreiter, R., Barde, Y. A., Bonhoeffer, T., and Korte, M. (2005). The
neurotrophin receptor p75NTR modulates long-term depression and regulates
the expression of AMPA receptor subunits in the hippocampus. Proc. Natl. Acad.
Sci. U.S.A. 102, 7362–7367. doi: 10.1073/pnas.0502460102
Segal, R. A., and Greenberg, M. E. (1996). Intracellular signaling pathways
activated by neurotrophic factors. Annu. Rev. Neurosci. 19, 463–489. doi:
10.1146/annurev.ne.19.030196.002335
Shimada, A., Mason, C. A., and Morrison, M. E. (1998). TrkB signaling modulates
spine density and morphology independent of dendrite structure in cultured
neonatal purkinje cells [Review]. J. Neurosci. 18, 8559–8570.
Sholl, D. A. (1953). Dendritic organization in the neurons of the visual and motor
cortices of the cat. J. Anat. 87, 387–406.
Sjostrom, P. J., Rancz, E. A., Roth, A., and Hausser, M. (2008). Dendritic
excitability and synaptic plasticity. Physiol. Rev. 88, 769–840. doi: 10.1152/phys-
rev.00016.2007
Stranahan, A. M. (2011). Physiological variability in brain-derived neu-
rotrophic factor expression predicts dendritic spine density in the mouse
dentate gyrus. Neurosci. Lett. 495, 60–62. doi: 10.1016/j.neulet.2011.
03.037
Frontiers in Synaptic Neuroscience www.frontiersin.org March 2014 | Volume 6 | Article 5 | 16
Kellner et al. BDNF effects on dendritic spines
Tanaka, J., Horiike, Y., Matsuzaki, M., Miyazaki, T., Ellis-Davies, G. C., and Kasai,
H. (2008). Protein synthesis and neurotrophin-dependent structural plasticity
of single dendritic spines. Science 319, 1683–1687. doi: 10.1126/science.1152864
Thoenen, H. (1991). The changing scene of neurotrophic factors. Trends Neurosci.
14, 165–170. doi: 10.1016/0166-2236(91)90097-E
Trang, T., Beggs, S., Wan, X., and Salter, M. W. (2009). P2X4-receptor-mediated
synthesis and release of brain-derived neurotrophic factor in microglia is
dependent on calcium and p38-mitogen-activated protein kinase activation. J.
Neurosci. 29, 3518–3528. doi: 10.1523/JNEUROSCI.5714-08.2009
Tyler, W. J., and Pozzo-Miller, L. (2003). Miniature synaptic transmission and
BDNF modulate dendritic spine growth and form in rat CA1 neurones.
J. Physiol. 553, 497–509. doi: 10.1113/jphysiol.2003.052639
Tyler, W. J., and Pozzo-Miller, L. D. (2001). BDNF enhances quantal neurotrans-
mitter release and increases the number of docked vesicles at the active zones of
hippocampal excitatory synapses. J. Neurosci. 21, 4249–4258.
Unger, T. J., Calderon, G. A., Bradley, L. C., Sena-Esteves, M., and Rios, M. (2007).
Selective deletion of Bdnf in the ventromedial and dorsomedial hypothala-
mus of adult mice results in hyperphagic behavior and obesity. J. Neurosci. 27,
14265–14274. doi: 10.1523/JNEUROSCI.3308-07.2007
Von Bohlen Und Halbach, O. (2010). Involvement of BDNF in age-
dependent alterations in the hippocampus. Front. Aging Neurosci. 2:36.
doi: 10.3389/fnagi.2010.00036
Woo, N. H., Teng, H. K., Siao, C. J., Chiaruttini, C., Pang, P. T., Milner, T. A., et al.
(2005). Activation of p75(NTR) by proBDNF facilitates hippocampal long-term
depression. Nat. Neurosci. 8, 1069–1077. doi: 10.1038/nn1510
Yamashita, T., and Tohyama, M. (2003). The p75 receptor acts as a displace-
ment factor that releases Rho from Rho-GDI. Nat. Neurosci. 6, 461–467. doi:
10.1038/nn1045
Yamashita, T., Tucker, K. L., and Barde, Y. A. (1999). Neurotrophin binding to
the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 24,
585–593. doi: 10.1016/S0896-6273(00)81114-9
Ying, S. W., Futter, M., Rosenblum, K., Webber, M. J., Hunt, S. P., Bliss, T. V., et al.
(2002). Brain-derived neurotrophic factor induces long-term potentiation in
intact adult hippocampus: requirement for ERK activation coupled to CREB
and upregulation of Arc synthesis. J. Neurosci. 22, 1532–1540.
Zafra, F., Hengerer, B., Leibrock, J., Thoenen, H., and Lindholm, D. (1990). Activity
dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is
mediated by non-NMDA glutamate receptors. EMBO J. 9, 3545–3550.
Zagrebelsky, M., Holz, A., Dechant, G., Barde, Y. A., Bonhoeffer, T., and Korte, M.
(2005). The p75 neurotrophin receptor negatively modulates dendrite complex-
ity and spine density in hippocampal neurons. J. Neurosci. 25, 9989–9999. doi:
10.1523/JNEUROSCI.2492-05.2005
Zagrebelsky, M., and Korte, M. (2013). Form follows function: BDNF and
its involvement in sculpting the function and structure of synapses.
Neuropharmacology 76, 628–638. doi: 10.1016/j.neuropharm.2013.05.029
Zakharenko, S. S., Patterson, S. L., Dragatsis, I., Zeitlin, S. O., Siegelbaum, S. A.,
Kandel, E. R., et al. (2003). Presynaptic BDNF required for a presynaptic but not
postsynaptic component of LTP at hippocampal CA1-CA3 synapses.Neuron 39,
975–990. doi: 10.1016/S0896-6273(03)00543-9
Zhou, Q., Homma, K. J., and Poo, M. M. (2004). Shrinkage of dendritic spines
associated with long-term depression of hippocampal synapses. Neuron 44,
749–757. doi: 10.1016/j.neuron.2004.11.011
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 16 December 2013; accepted: 01 March 2014; published online: 20 March
2014.
Citation: Kellner Y, Gödecke N, Dierkes T, Thieme N, ZagrebelskyM and Korte M
(2014) The BDNF effects on dendritic spines of mature hippocampal neurons depend
on neuronal activity. Front. Synaptic Neurosci. 6:5. doi: 10.3389/fnsyn.2014.00005
This article was submitted to the journal Frontiers in Synaptic Neuroscience.
Copyright © 2014 Kellner, Gödecke, Dierkes, Thieme, Zagrebelsky and Korte. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply with
these terms.
Frontiers in Synaptic Neuroscience www.frontiersin.org March 2014 | Volume 6 | Article 5 | 17
